Article Versions Notes

Rinne SS, Yin W, Borras AM, Abouzayed A, Leitao CD, Vorobyeva A, Löfblom J, Ståhl S, Orlova A, Gräslund T. Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules. Biomedicines. 2022; 10(6):1293. https://doi.org/10.3390/biomedicines10061293

Rinne, Sara S., Wen Yin, Anna Mestre Borras, Ayman Abouzayed, Charles Dahlsson Leitao, Anzhelika Vorobyeva, John Löfblom, Stefan Ståhl, Anna Orlova, and Torbjörn Gräslund. 2022. "Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules" Biomedicines 10, no. 6: 1293. https://doi.org/10.3390/biomedicines10061293

Rinne, S. S., Yin, W., Borras, A. M., Abouzayed, A., Leitao, C. D., Vorobyeva, A., Löfblom, J., Ståhl, S., Orlova, A., & Gräslund, T. (2022). Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules. Biomedicines, 10(6), 1293. https://doi.org/10.3390/biomedicines10061293